Evidence map›Paper›PMID 7487926›Full record

ArticleThe Biochemical journal1995

The activation of distinct mitogen-activated protein kinase cascades is required for the stimulation of 2-deoxyglucose uptake by interleukin-1 and insulin-like growth factor-1 in KB cells.

G W Gould, A Cuenda, F J Thomson, P Cohen

Open access · greenAbstract read
In one paragraph

Article in The Biochemical journal, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 91 citations in OpenAlex.

  1. Resistance of E2F4DN to p38Scientific reports · 2026
    Article
  2. Morpho-Physiological and Proteomic Analyses ofPlants (Basel, Switzerland) · 2019
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. IL-1 resets glucose homeostasis at central levels.Proceedings of the National Academy of Sciences of the United States of America · 2006
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

G W GouldDivision of Biochemistry and Molecular Biology, University of Glasgow, U.K.
A Cuenda
F J Thomson
P Cohen
University of Glasgow · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

The uptake of 2-deoxyglucose into KB cells was stimulated about 2-fold by interleukin-1 (IL1), anisomycin or insulin-like growth factor-1 (IGF1). Stimulation by IL1 and anisomycin was prevented by SB 203580, a specific inhibitor of the mitogen-activated protein (MAP) kinase homologue termed 're-activating kinase' [RK; also known as p38, p40 and CSBP (cytokine synthesis anti-inflammatory-drug-binding protein)], but was unaffected by PD 98059, a specific inhibitor of the activation of the classical MAP kinase pathway. In contrast, the stimulation of 2-deoxyglucose uptake by IGF1 was blocked by PD 98059 and unaffected by SB 203580. Consistent with these observations, IL1 and anisomycin were potent activators of MAP kinase-activated protein (MAPKAP) kinase-2, a physiological substrate of RK, whereas IGF1 was only a very weak activator of MAPKAP kinase-2. Conversely, IGF1 was a stronger activator of p42 MAP kinase than IL1 or anisomycin. These results imply that the activation of distinct MAP kinase pathways is required for the stimulation of glucose transport by IL1/anisomycin and IGF1 in KB cells, and suggest that the combined use of SB 203580 and PD 98059 is a powerful new approach to explore the roles of different MAP kinase cascades in cell regulation.

Indexed as

Mitogen-Activated Protein KinasesAnisomycinCalcium-Calmodulin-Dependent Protein KinasesDeoxyglucoseEnzyme ActivationEnzyme InhibitorsFlavonoidsHumansImidazolesInsulin-Like Growth Factor IInterleukin-1KB CellsMonosaccharide Transport Proteinsp38 Mitogen-Activated Protein KinasesProtein Synthesis InhibitorsPyridines2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-oneAnisomycinCalcium-Calmodulin-Dependent Protein KinasesDeoxyglucoseEnzyme InhibitorsFlavonoidsImidazolesInsulin-Like Growth Factor IInterleukin-1Mitogen-Activated Protein KinasesMonosaccharide Transport Proteinsp38 Mitogen-Activated Protein KinasesProtein Synthesis InhibitorsPyridinesSB 203580

Identifiers

PMID7487926
PMCPMC1136064
OpenAlexW105320007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.